13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q3 2021. See the latest, Q2 2026 →
Reported value
$428.65B
−0.2% on the quarter before
Positions
441
26 new · 21 sold out
Top 10
29.9%
of the value
Est. gain
+$291.7M
on stocks held all quarter
Est. return
+0.1%
on those stocks since Q2 2021
Positions as of Sep 30, 2021, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 47% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2021. Striped tiles are options.
Largest buys
Since Q2 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- General Electric Co~$3.99BNew · 0.0% → 0.9%+38,717,586 shares
- Sea~$1.15BAdded · 0.3% → 0.6%+3,609,897 shares
- Amazon~$912.1MAdded · 3.0% → 3.1%+277,637 shares
- Affirm~$861.5MAdded · 0.1% → 0.4%+7,231,859 shares
- Morgan Stanley~$855.0MAdded · 0.0% → 0.2%+8,786,406 shares
- Pg&E Corp~$854.5MAdded · 0.2% → 0.4%+89,015,156 shares
- Kimberly-Clark Corp~$809.7MAdded · 0.0% → 0.2%+6,113,540 shares
- Snowflake~$648.4MAdded · 0.2% → 0.3%+2,144,156 shares
- Okta~$612.3MAdded · 0.0% → 0.1%+2,579,882 shares
- Paycom~$529.8MAdded · 0.0% → 0.2%+1,068,686 shares
Largest sells
Since Q2 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- General Electric Co~$2.99BSold out · 0.7% → 0.0%−221,874,950 shares
- Eog Res Inc~$1.49BCut · 1.2% → 0.8%−18,526,490 shares
- Mastercard~$1.17BCut · 1.5% → 1.2%−3,367,806 shares
- Jpmorgan Chase & Co~$1.14BCut · 1.5% → 1.3%−6,963,653 shares
- Diamondback Energy Inc~$852.8MCut · 0.3% → 0.1%−9,007,664 shares
- Zimmer Biomet Holdings Inc~$614.0MCut · 0.4% → 0.2%−4,194,894 shares
- Burlington Stores Inc~$598.1MCut · 0.5% → 0.3%−2,109,121 shares
- Amgen Inc~$550.0MCut · 1.7% → 1.3%−2,586,436 shares
- Vale S A~$514.7MCut · 1.4% → 0.8%−36,894,171 shares
- Broadcom~$500.9MCut · 3.0% → 2.9%−1,032,830 shares
Holdings
As of Sep 30, 2021. Changes are in shares against Jun 30, 2021, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −0.3% · price +4.1% | 6.2% | $26.58B | +$1.04B | ||||||||
| NetflixCOM · shares −1.4% · price +15.5% | 4.2% | $17.79B | +$2.39B | ||||||||
| MetaCL A · shares +2.7% · price −2.4% | 3.2% | $13.72B | −$327.4M | ||||||||
| AmazonCOM · shares +7.4% · price −4.5% | 3.1% | $13.17B | −$578.9M | ||||||||
| BroadcomCOM · shares −3.8% · price +1.7% | 2.9% | $12.56B | +$209.6M | ||||||||
| AlphabetCAP STK CL A · shares −1.6% · price +9.5% | 2.4% | $10.08B | +$873.5M | ||||||||
| Abbott LabsCOM · shares −1.6% · price +1.9% | 2.3% | $9.98B | +$185.8M | ||||||||
| AlphabetCAP STK CL C · shares −3.5% · price +6.3% | 1.9% | $8.11B | +$483.5M | ||||||||
| Comcast Corp NewCL A · shares +5.7% · price −1.9% | 1.9% | $8.03B | −$147.9M | ||||||||
| Gilead Sciences IncCOM · shares −1.8% · price +1.4% | 1.9% | $8.00B | +$113.4M | ||||||||
| Unitedhealth Group IncCOM · shares −0.6% · price −2.4% | 1.6% | $7.04B | −$174.7M | ||||||||
| MercadoLibreCOM · shares +3.1% · price +7.8% | 1.5% | $6.47B | +$454.4M | ||||||||
| Jpmorgan Chase & CoCOM · shares −16% · price +5.2% | 1.3% | $5.78B | +$287.7M | ||||||||
| Amgen IncCOM · shares −8.8% · price −12.8% | 1.3% | $5.68B | −$831.1M | ||||||||
| Philip Morris Intl IncCOM · shares +1.8% · price −4.4% | 1.3% | $5.48B | −$245.2M | ||||||||
| Thermo Fisher Scientific IncCOM · shares +2.0% · price +13.3% | 1.2% | $5.28B | +$605.8M | ||||||||
| General Mtrs CoCOM · shares −1.3% · price −10.9% | 1.2% | $5.01B | −$614.5M | ||||||||
| MastercardCL A · shares −19% · price −4.8% | 1.2% | $4.99B | −$249.6M | ||||||||
| Home Depot IncCOM · shares −6.8% · price +2.9% | 1.1% | $4.88B | +$139.4M | ||||||||
| Raytheon Technologies CorpCOM · shares +8.8% · price +0.8% | 1.1% | $4.52B | +$31.4M | ||||||||
| Canadian Nat Res LtdCOM · shares −7.8% · price +0.7% | 0.99% | $4.26B | +$30.3M | ||||||||
| ServiceNowCOM · shares −0.5% · price +13.2% | 0.97% | $4.14B | +$483.4M | ||||||||
| Csx CorpCOM · shares −5.0% · price −7.3% | 0.94% | $4.01B | −$315.4M | ||||||||
| General Electric CoCOM NEW · shares New | 0.93% | $3.99B | — | ||||||||
| Linde PlcSHS · shares −0.5% · price +1.5% | 0.90% | $3.86B | +$58.7M | ||||||||
| Total · 441 positions | 100% | $428.65B | +$291.7M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2021 to Q3 2021: 415 stocks held throughout, up $291.7M (+0.1%).
- Netflix+$2.39B+16%
- Microsoft+$1.04B+4%
- Atlassian Corp Plc+$1.01B+52%
- Alphabet+$873.5M+9%
- Thermo Fisher Scientific Inc+$605.8M+13%
- Amazon−$578.9M−5%
- General Mtrs Co−$614.5M−11%
- Amgen Inc−$831.1M−13%
- Stoneco Ltd−$934.7M−48%
- Vale S A−$2.04B−39%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |